Wednesday, April 7, 2010
What can you do when Pharma says no?
The first step Spong suggests is:
Call your reluctant colleagues and clients out on the phantasms that are issues for them, but rather less so in reality – by which I means do a real needs assessment based on their fear of regulatory constraints (which even the regulators don’t agree with); ROI (which needs to be redefined as impact/impuse/inclusion/involvement or (as a negative measure) ignoring); AER (1 in 500 in the USA; Talk the group’s concerns to death. Make the problem go away – if only for this team. Turn them into advocates, internally.
Read the rest of the article here. What do you think? Do you have any contributions to Dr. Spong's list about what could be done to encourage social Pharma in the future?